Dynamic Metabolic Profiling of Urine From Type 2 Diabetic KK-Ay Mice Treated with Repaglinide by GC-MS

摘要

Repaglinide is a short-acting insulin secretagogue, commonly used for the treatment of type 2 diabetes. In this paper, metabolomics were first applied to research of dynamic urine metabolic profiling and biomarkers of type 2 diabetic KK-Ay mice treated with repaglinide based on GC-MS. Twenty diabetic KK-Ay mice were randomly assigned to four groups and fed with repaglinide for 6, 9, 12, and 14 weeks, respectively. Five C57BL/6Â J mice were used as the healthy control group and fed with water as contrast. The PCA scores plot of the identified 41 metabolites showed that as treating time went on, the diabetic groups got closer to the healthy group. Furthermore, five marker metabolites, d-Glucose, d-Galactose, 1,5-Anhydro-d-glucitol, myo-inositol and tartaric acid were screened out, which have similar change footprints of the whole metabolic profiles. The results demonstrated that repaglinide not only regulates the sugars and polyalcohol but also the organic acid in the organism. This work has illustrated the potential of metabolomics to disease diagnosis, pharmacology, and pharmacodynamics research.View full textDownload full textKeywordsKK-Ay mice, Metabolomics, Principal component analysis (pca), Repaglinide, Type 2 diabetes mellitusRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/00032719.2012.677977